A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients

NCT03866499 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

369

Enrollment

INDUSTRY

Sponsor class

Conditions

NSCLC

Interventions

DRUG: BPI-7711
DRUG: Gefitinib
DRUG: Placebo Tablet
DRUG: Placebo capsule

Sponsor

Beta Pharma Shanghai